{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T23:54:57Z","timestamp":1794354897513,"version":"4.9.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,3,18]],"date-time":"2020-03-18T00:00:00Z","timestamp":1584489600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,3,18]],"date-time":"2020-03-18T00:00:00Z","timestamp":1584489600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"swiss national foundation","award":["324730-144054 and 33IC30_179636"],"award-info":[{"award-number":["324730-144054 and 33IC30_179636"]}]},{"name":"European Union\u2019s Seventh Framework Program","award":["HEALTH-2010\u2013260338"],"award-info":[{"award-number":["HEALTH-2010\u2013260338"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Crit Care"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Candidemia is an opportunistic infection associated with high morbidity and mortality in patients hospitalized both inside and outside intensive care units (ICUs). Identification of patients at risk is crucial to ensure prompt antifungal therapy. We sought to assess risk factors for candidemia and death, both outside and inside ICUs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      This prospective multicenter matched case-control study involved six teaching hospitals in Switzerland and France. Cases were defined by positive blood cultures for\n                      <jats:italic>Candida<\/jats:italic>\n                      sp. Controls were matched to cases using the following criteria: age, hospitalization ward, hospitalization duration, and, when applicable, type of surgery. One to three controls were enrolled by case. Risk factors were analyzed by univariate and multivariate conditional regression models, as a basis for a new scoring system to predict candidemia.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>One hundred ninety-two candidemic patients and 411 matched controls were included. Forty-four percent of included patients were hospitalized in ICUs, and 56% were hospitalized outside ICUs. Independent risk factors for candidemia in the ICU population included total parenteral nutrition, acute kidney injury, heart disease, prior septic shock, and exposure to aminoglycoside antibiotics. Independent risk factors for candidemia in the non-ICU population included central venous catheter, total parenteral nutrition, and exposure to glycopeptides and nitroimidazoles. The accuracy of the scores based on these risk factors is better in the ICU than in the non-ICU population. Independent risk factors for death in candidemic patients included septic shock, acute kidney injury, and the number of antibiotics to which patients were exposed before candidemia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>While this study shows a role for known and novel risk factors for candidemia, it specifically highlights important differences in their distribution according to the hospital setting (ICU versus non-ICU).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study provides novel risk scores for candidemia accounting for the hospital setting and recent progress in patients\u2019 management strategies and fungal epidemiology.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13054-020-2766-1","type":"journal-article","created":{"date-parts":[[2020,3,18]],"date-time":"2020-03-18T20:04:36Z","timestamp":1584561876000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":174,"title":["Risk factors for candidemia: a prospective matched case-control study"],"prefix":"10.1186","volume":"24","author":[{"name":"the FUNGINOS","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6017-5353","authenticated-orcid":false,"given":"Julien","family":"Poissy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Allfun French Study Groups","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauro","family":"Damonti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Bignon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Khanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Von Kietzell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katia","family":"Boggian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dionysios","family":"Neofytos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanny","family":"Vuotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Coiteux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florent","family":"Artru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Zimmerli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Luc","family":"Pagani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Calandra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boualem","family":"Sendid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Poulain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"van Delden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Lamoth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oscar","family":"Marchetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Yves","family":"Bochud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,18]]},"reference":[{"issue":"3","key":"2766_CR1","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1086\/421946","volume":"39","author":"H Wisplinghoff","year":"2004","unstructured":"Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis. 2004;39(3):309\u201317.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"2766_CR2","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1128\/JCM.01811-10","volume":"49","author":"MC Arendrup","year":"2011","unstructured":"Arendrup MC, Bruun B, Christensen JJ, Fuursted K, Johansen HK, Kjaeldgaard P, Knudsen JD, Kristensen L, Moller J, Nielsen L, et al. National surveillance of fungemia in Denmark (2004 to 2009). J Clin Microbiol. 2011;49(1):325\u201334.","journal-title":"J Clin Microbiol"},{"issue":"10","key":"2766_CR3","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1093\/cid\/cis697","volume":"55","author":"AA Cleveland","year":"2012","unstructured":"Cleveland AA, Farley MM, Harrison LH, Stein B, Hollick R, Lockhart SR, Magill SS, Derado G, Park BJ, Chiller TM. Changes in incidence and antifungal drug resistance in candidemia: results from population-based laboratory surveillance in Atlanta and Baltimore, 2008-2011. Clin Infect Dis. 2012;55(10):1352\u201361.","journal-title":"Clin Infect Dis"},{"issue":"9","key":"2766_CR4","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1007\/s00134-014-3408-3","volume":"40","author":"O Lortholary","year":"2014","unstructured":"Lortholary O, Renaudat C, Sitbon K, Madec Y, Denoeud-Ndam L, Wolff M, Fontanet A, Bretagne S, Dromer F, French Mycosis Study G. Worrisome trends in incidence and mortality of candidemia in intensive care units (Paris area, 2002-2010). Intensive Care Med. 2014;40(9):1303\u201312.","journal-title":"Intensive Care Med"},{"issue":"suppl_1","key":"2766_CR5","doi-asserted-by":"publisher","first-page":"i4","DOI":"10.1093\/jac\/dkx444","volume":"73","author":"F Lamoth","year":"2018","unstructured":"Lamoth F, Lockhart SR, Berkow EL, Calandra T. Changes in the epidemiological landscape of invasive candidiasis. J Antimicrob Chemother. 2018;73(suppl_1):i4\u2013i13.","journal-title":"J Antimicrob Chemother"},{"issue":"4","key":"2766_CR6","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1093\/jac\/dkx047","volume":"72","author":"B Chapman","year":"2017","unstructured":"Chapman B, Slavin M, Marriott D, Halliday C, Kidd S, Arthur I, Bak N, Heath CH, Kennedy K, Morrissey CO, et al. Changing epidemiology of candidaemia in Australia. J Antimicrob Chemother. 2017;72(4):1103\u20138.","journal-title":"J Antimicrob Chemother"},{"key":"2766_CR7","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s13054-016-1229-1","volume":"20","author":"JA Paiva","year":"2016","unstructured":"Paiva JA, Pereira JM, Tabah A, Mikstacki A, de Carvalho FB, Koulenti D, Ruckly S, Cakar N, Misset B, Dimopoulos G, et al. Characteristics and risk factors for 28-day mortality of hospital acquired fungemias in ICUs: data from the EUROBACT study. Crit Care. 2016;20:53.","journal-title":"Crit Care"},{"issue":"4","key":"2766_CR8","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1097\/CCM.0b013e318206c1ca","volume":"39","author":"DH Kett","year":"2011","unstructured":"Kett DH, Azoulay E, Echeverria PM, Vincent JL, Extended Prevalence of infection in ICUSGoI. Candida bloodstream infections in intensive care units: analysis of the extended prevalence of infection in intensive care unit study. Crit Care Med. 2011;39(4):665\u201370.","journal-title":"Crit Care Med"},{"issue":"10","key":"2766_CR9","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1007\/s00134-014-3400-y","volume":"40","author":"AL Colombo","year":"2014","unstructured":"Colombo AL, Guimaraes T, Sukienik T, Pasqualotto AC, Andreotti R, Queiroz-Telles F, Nouer SA, Nucci M. Prognostic factors and historical trends in the epidemiology of candidemia in critically ill patients: an analysis of five multicenter studies sequentially conducted over a 9-year period. Intensive Care Med. 2014;40(10):1489\u201398.","journal-title":"Intensive Care Med"},{"issue":"2","key":"2766_CR10","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1086\/321811","volume":"33","author":"Henry\u00a0M. Blumberg","year":"2001","unstructured":"Blumberg HM, Jarvis WR, Soucie JM, Edwards JE, Patterson JE, Pfaller MA, Rangel-Frausto MS, Rinaldi MG, Saiman L, Wiblin RT et al: Risk factors for candidal bloodstream infections in surgical intensive care unit patients: the NEMIS prospective multicenter study. The National Epidemiology of Mycosis Survey. Clin Infect Dis 2001, 33(2):177\u2013186.","journal-title":"Clinical Infectious Diseases"},{"issue":"21","key":"2766_CR11","doi-asserted-by":"publisher","first-page":"2323","DOI":"10.1001\/jama.2009.1754","volume":"302","author":"JL Vincent","year":"2009","unstructured":"Vincent JL, Rello J, Marshall J, Silva E, Anzueto A, Martin CD, Moreno R, Lipman J, Gomersall C, Sakr Y, et al. International study of the prevalence and outcomes of infection in intensive care units. JAMA. 2009;302(21):2323\u20139.","journal-title":"JAMA"},{"issue":"6","key":"2766_CR12","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/S0002-9343(02)01248-2","volume":"113","author":"SI Blot","year":"2002","unstructured":"Blot SI, Vandewoude KH, Hoste EA, Colardyn FA. Effects of nosocomial candidemia on outcomes of critically ill patients. Am J Med. 2002;113(6):480\u20135.","journal-title":"Am J Med"},{"issue":"9","key":"2766_CR13","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1086\/378745","volume":"37","author":"O Gudlaugsson","year":"2003","unstructured":"Gudlaugsson O, Gillespie S, Lee K, Vande Berg J, Hu J, Messer S, Herwaldt L, Pfaller M, Diekema D. Attributable mortality of nosocomial candidemia, revisited. Clin Infect Dis. 2003;37(9):1172\u20137.","journal-title":"Clin Infect Dis"},{"issue":"3","key":"2766_CR14","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1053\/jcrc.2002.35815","volume":"17","author":"G Leleu","year":"2002","unstructured":"Leleu G, Aegerter P, Guidet B, College des Utilisateurs de Base de Donnees en R. Systemic candidiasis in intensive care units: a multicenter, matched-cohort study. J Crit Care. 2002;17(3):168\u201375.","journal-title":"J Crit Care"},{"issue":"6","key":"2766_CR15","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1164\/rccm.200407-916OC","volume":"171","author":"PW Kim","year":"2005","unstructured":"Kim PW, Perl TM, Keelaghan EF, Langenberg P, Perencevich EN, Harris AD, Song X, Roghmann MC. Risk of mortality with a bloodstream infection is higher in the less severely ill at admission. Am J Respir Crit Care Med. 2005;171(6):616\u201320.","journal-title":"Am J Respir Crit Care Med"},{"issue":"12","key":"2766_CR16","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1093\/cid\/cis305","volume":"54","author":"M Kollef","year":"2012","unstructured":"Kollef M, Micek S, Hampton N, Doherty JA, Kumar A. Septic shock attributed to Candida infection: importance of empiric therapy and source control. Clin Infect Dis. 2012;54(12):1739\u201346.","journal-title":"Clin Infect Dis"},{"issue":"6","key":"2766_CR17","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1097\/QCO.0b013e3283177967","volume":"21","author":"EG Playford","year":"2008","unstructured":"Playford EG, Eggimann P, Calandra T. Antifungals in the ICU. Curr Opin Infect Dis. 2008;21(6):610\u20139.","journal-title":"Curr Opin Infect Dis"},{"issue":"11","key":"2766_CR18","doi-asserted-by":"publisher","first-page":"3435","DOI":"10.1128\/JCM.01283-12","volume":"50","author":"SR Lockhart","year":"2012","unstructured":"Lockhart SR, Iqbal N, Cleveland AA, Farley MM, Harrison LH, Bolden CB, Baughman W, Stein B, Hollick R, Park BJ, et al. Species identification and antifungal susceptibility testing of Candida bloodstream isolates from population-based surveillance studies in two U.S. cities from 2008 to 2011. J Clin Microbiol. 2012;50(11):3435\u201342.","journal-title":"J Clin Microbiol"},{"issue":"12","key":"2766_CR19","doi-asserted-by":"publisher","first-page":"7465","DOI":"10.1128\/AAC.01973-15","volume":"59","author":"RK Shields","year":"2015","unstructured":"Shields RK, Nguyen MH, Press EG, Cumbie R, Driscoll E, Pasculle AW, Clancy CJ. Rate of FKS mutations among consecutive Candida isolates causing bloodstream infection. Antimicrob Agents Chemother. 2015;59(12):7465\u201370.","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"2766_CR20","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1097\/QCO.0000000000000215","volume":"28","author":"RK Shields","year":"2015","unstructured":"Shields RK, Nguyen MH, Clancy CJ. Clinical perspectives on echinocandin resistance among Candida species. Curr Opin Infect Dis. 2015;28(6):514\u201322.","journal-title":"Curr Opin Infect Dis"},{"key":"2766_CR21","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.ejim.2017.03.005","volume":"41","author":"M Falcone","year":"2017","unstructured":"Falcone M, Tiseo G, Tascini C, Russo A, Sozio E, Raponi G, Rosin C, Pignatelli P, Carfagna P, Farcomeni A, et al. Assessment of risk factors for candidemia in non-neutropenic patients hospitalized in internal medicine wards: a multicenter study. Eur J Intern Med. 2017;41:33\u20138.","journal-title":"Eur J Intern Med"},{"issue":"3","key":"2766_CR22","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1097\/01.CCM.0000202208.37364.7D","volume":"34","author":"C Leon","year":"2006","unstructured":"Leon C, Ruiz-Santana S, Saavedra P, Almirante B, Nolla-Salas J, Alvarez-Lerma F, Garnacho-Montero J, Leon MA, Group ES. A bedside scoring system (\u201cCandida score\u201d) for early antifungal treatment in nonneutropenic critically ill patients with Candida colonization. Crit Care Med. 2006;34(3):730\u20137.","journal-title":"Crit Care Med"},{"issue":"4","key":"2766_CR23","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s10096-007-0270-z","volume":"26","author":"L Ostrosky-Zeichner","year":"2007","unstructured":"Ostrosky-Zeichner L, Sable C, Sobel J, Alexander BD, Donowitz G, Kan V, Kauffman CA, Kett D, Larsen RA, Morrison V, et al. Multicenter retrospective development and validation of a clinical prediction rule for nosocomial invasive candidiasis in the intensive care setting. Eur J Clin Microbiol Infect Dis. 2007;26(4):271\u20136.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"11","key":"2766_CR24","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1093\/cid\/ciw610","volume":"63","author":"EG Playford","year":"2016","unstructured":"Playford EG, Lipman J, Jones M, Lau AF, Kabir M, Chen SC, Marriott DJ, Seppelt I, Gottlieb T, Cheung W, et al. Problematic dichotomization of risk for intensive care unit (ICU)-acquired invasive candidiasis: results using a risk-predictive model to categorize 3 levels of risk from a multicenter prospective cohort of Australian ICU patients. Clin Infect Dis. 2016;63(11):1463\u20139.","journal-title":"Clin Infect Dis"},{"issue":"10","key":"2766_CR25","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1001\/archinte.1989.00390100145030","volume":"149","author":"SB Wey","year":"1989","unstructured":"Wey SB, Mori M, Pfaller MA, Woolson RF, Wenzel RP. Risk factors for hospital-acquired candidemia. A matched case-control study. Arch Intern Med. 1989;149(10):2349\u201353.","journal-title":"Arch Intern Med"},{"issue":"6","key":"2766_CR26","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1186\/cc9239","volume":"14","author":"M Bassetti","year":"2010","unstructured":"Bassetti M, Mikulska M, Viscoli C. Bench-to-bedside review: therapeutic management of invasive candidiasis in the intensive care unit. Crit Care. 2010;14(6):244.","journal-title":"Crit Care"},{"issue":"5","key":"2766_CR27","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1097\/CCM.0b013e31819daa14","volume":"37","author":"C Leon","year":"2009","unstructured":"Leon C, Ruiz-Santana S, Saavedra P, Galvan B, Blanco A, Castro C, Balasini C, Utande-Vazquez A, Gonzalez de Molina FJ, Blasco-Navalproto MA, et al. Usefulness of the \u201cCandida score\u201d for discriminating between Candida colonization and invasive candidiasis in non-neutropenic critically ill patients: a prospective multicenter study. Crit Care Med. 2009;37(5):1624\u201333.","journal-title":"Crit Care Med"},{"key":"2766_CR28","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1186\/s12879-016-1803-9","volume":"16","author":"J Shahin","year":"2016","unstructured":"Shahin J, Allen EJ, Patel K, Muskett H, Harvey SE, Edgeworth J, Kibbler CC, Barnes RA, Biswas S, Soni N, et al. Predicting invasive fungal disease due to Candida species in non-neutropenic, critically ill, adult patients in United Kingdom critical care units. BMC Infect Dis. 2016;16:480.","journal-title":"BMC Infect Dis"},{"issue":"2","key":"2766_CR29","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1111\/1469-0691.12210","volume":"20","author":"C Lacroix","year":"2014","unstructured":"Lacroix C, Gicquel A, Sendid B, Meyer J, Accoceberry I, Francois N, Morio F, Desoubeaux G, Chandenier J, Kauffmann-Lacroix C, et al. Evaluation of two matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) systems for the identification of Candida species. Clin Microbiol Infect. 2014;20(2):153\u20138.","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"2766_CR30","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3109\/13693786.2012.693631","volume":"51","author":"B Sendid","year":"2013","unstructured":"Sendid B, Ducoroy P, Francois N, Lucchi G, Spinali S, Vagner O, Damiens S, Bonnin A, Poulain D, Dalle F. Evaluation of MALDI-TOF mass spectrometry for the identification of medically-important yeasts in the clinical laboratories of Dijon and Lille hospitals. Med Mycol. 2013;51(1):25\u201332.","journal-title":"Med Mycol"},{"issue":"6","key":"2766_CR31","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1097\/00000658-199412000-00008","volume":"220","author":"D Pittet","year":"1994","unstructured":"Pittet D, Monod M, Suter PM, Frenk E, Auckenthaler R. Candida colonization and subsequent infections in critically ill surgical patients. Ann Surg. 1994;220(6):751\u20138.","journal-title":"Ann Surg"},{"issue":"7","key":"2766_CR32","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/j.acra.2013.03.004","volume":"20","author":"MS Pepe","year":"2013","unstructured":"Pepe MS, Fan J, Seymour CW. Estimating the receiver operating characteristic curve in studies that match controls to cases on covariates. Acad Radiol. 2013;20(7):863\u201373.","journal-title":"Acad Radiol"},{"issue":"1","key":"2766_CR33","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1002\/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3","volume":"3","author":"WJ Youden","year":"1950","unstructured":"Youden WJ. Index for rating diagnostic tests. Cancer. 1950;3(1):32\u20135.","journal-title":"Cancer"},{"issue":"4","key":"2766_CR34","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1093\/clinchem\/39.4.561","volume":"39","author":"MH Zweig","year":"1993","unstructured":"Zweig MH, Campbell G. Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin Chem. 1993;39(4):561\u201377.","journal-title":"Clin Chem"},{"key":"2766_CR35","unstructured":"Monitoring of 1,3-Beta-D-Glucan in High-Risk Surgical ICU Patients for Early Diagnosis of Invasive Candidiasis: a Prospective Study of the Fungal Infection Network of Switzerland (FUNGINOS). Poster Presentation # M-1071. 50th ICAAC, September 12\u201315 2010."},{"issue":"3","key":"2766_CR36","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/s00134-005-2571-y","volume":"31","author":"PE Charles","year":"2005","unstructured":"Charles PE, Dalle F, Aube H, Doise JM, Quenot JP, Aho LS, Chavanet P, Blettery B. Candida spp. colonization significance in critically ill medical patients: a prospective study. Intensive Care Med. 2005;31(3):393\u2013400.","journal-title":"Intensive Care Med"},{"issue":"12","key":"2766_CR37","doi-asserted-by":"publisher","first-page":"2733","DOI":"10.1128\/JCM.28.12.2733-2738.1990","volume":"28","author":"DR Reagan","year":"1990","unstructured":"Reagan DR, Pfaller MA, Hollis RJ, Wenzel RP. Characterization of the sequence of colonization and nosocomial candidemia using DNA fingerprinting and a DNA probe. J Clin Microbiol. 1990;28(12):2733\u20138.","journal-title":"J Clin Microbiol"},{"issue":"10","key":"2766_CR38","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1038\/nri3897","volume":"15","author":"MG Netea","year":"2015","unstructured":"Netea MG, Joosten LA, van der Meer JW, Kullberg BJ, van de Veerdonk FL. Immune defence against Candida fungal infections. Nat Rev Immunol. 2015;15(10):630\u201342.","journal-title":"Nat Rev Immunol"},{"issue":"8","key":"2766_CR39","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1007\/s10096-016-2658-0","volume":"35","author":"L Lagunes","year":"2016","unstructured":"Lagunes L, Rello J. Invasive candidiasis: from mycobiome to infection, therapy, and prevention. Eur J Clin Microbiol Infect Dis. 2016;35(8):1221\u20136.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2766_CR40","doi-asserted-by":"publisher","first-page":"105","DOI":"10.3389\/fcimb.2013.00105","volume":"3","author":"FR Demehri","year":"2013","unstructured":"Demehri FR, Barrett M, Ralls MW, Miyasaka EA, Feng Y, Teitelbaum DH. Intestinal epithelial cell apoptosis and loss of barrier function in the setting of altered microbiota with enteral nutrient deprivation. Front Cell Infect Microbiol. 2013;3:105.","journal-title":"Front Cell Infect Microbiol"},{"issue":"10","key":"2766_CR41","doi-asserted-by":"publisher","first-page":"e110396","DOI":"10.1371\/journal.pone.0110396","volume":"9","author":"JK Harris","year":"2014","unstructured":"Harris JK, El Kasmi KC, Anderson AL, Devereaux MW, Fillon SA, Robertson CE, Wagner BD, Stevens MJ, Pace NR, Sokol RJ. Specific microbiome changes in a mouse model of parenteral nutrition associated liver injury and intestinal inflammation. PLoS One. 2014;9(10):e110396.","journal-title":"PLoS One"},{"issue":"6","key":"2766_CR42","doi-asserted-by":"publisher","first-page":"2367","DOI":"10.1128\/IAI.01520-08","volume":"77","author":"DA Antonopoulos","year":"2009","unstructured":"Antonopoulos DA, Huse SM, Morrison HG, Schmidt TM, Sogin ML, Young VB. Reproducible community dynamics of the gastrointestinal microbiota following antibiotic perturbation. Infect Immun. 2009;77(6):2367\u201375.","journal-title":"Infect Immun"},{"issue":"3","key":"2766_CR43","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1080\/13693780500395225","volume":"44","author":"G Samonis","year":"2006","unstructured":"Samonis G, Maraki S, Leventakos K, Spanaki AM, Kateifidis A, Galanakis E, Tselentis Y, Falagas ME, Mantadakis E. Comparative effects of ertapenem, imipenem, and meropenem on the colonization of the gastrointestinal tract of mice by Candida albicans. Med Mycol. 2006;44(3):233\u20135.","journal-title":"Med Mycol"},{"issue":"12","key":"2766_CR44","doi-asserted-by":"publisher","first-page":"5189","DOI":"10.1128\/AAC.49.12.5189.2005","volume":"49","author":"G Samonis","year":"2005","unstructured":"Samonis G, Kofteridis DP, Maraki S, Alegakis D, Mantadakis E, Papadakis JA, Gikas AH, Falagas ME. Levofloxacin and moxifloxacin increase human gut colonization by Candida species. Antimicrob Agents Chemother. 2005;49(12):5189.","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"2766_CR45","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1080\/13693780500265980","volume":"44","author":"G Samonis","year":"2006","unstructured":"Samonis G, Maraki S, Barbounakis E, Leventakos K, Lamaris G, Rovithi M, Hatjiioannou I, Potolidis E, Tselentis Y, Mantadakis E. Effects of vancomycin, teicoplanin, linezolid, quinupristin-dalfopristin, and telithromycin on murine gut colonization by Candida albicans. Med Mycol. 2006;44(2):193\u20136.","journal-title":"Med Mycol"}],"container-title":["Critical Care"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-020-2766-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13054-020-2766-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-020-2766-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,17]],"date-time":"2021-03-17T20:39:50Z","timestamp":1616013590000},"score":1,"resource":{"primary":{"URL":"https:\/\/ccforum.biomedcentral.com\/articles\/10.1186\/s13054-020-2766-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,18]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["2766"],"URL":"https:\/\/doi.org\/10.1186\/s13054-020-2766-1","relation":{},"ISSN":["1364-8535"],"issn-type":[{"value":"1364-8535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,18]]},"assertion":[{"value":"1 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All patients gave written informed consent before participation in the study. Written informed consent was waived by the patients\u2019 legal representative in the case of incapacity before inclusion. The protocol was approved by the Institutional Review Board of Lille University Hospital \u201cComit\u00e9 de Protection des Personnes Nord Ouest IV\u201d and by the Swiss Network of Ethics Committees. The study was registered on ClinicalTrials.gov (NCT02841501).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"TC has been in an advisory board for Astellas, Basilea, Cidara, MSD, Sobi, Thermofisher, GE Healthcare, and in a Data Monitoring Board for Novartis. The other authors declare that they have no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"109"}}